Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2)

Blood

Volumn 107, Issue 1, 2006, Pages 349-354

  Iolascon, Achille ^a   D'Apolito, Maria ^b   Servedio, Veronica ^b   Cimmino, Flora ^b   Piga, Antonio ^b   Camaschella, Clara ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; RECOMBINANT ERYTHROPOIETIN;

ARTICLE; BLOOD TRANSFUSION; CASE REPORT; DISEASE SEVERITY; ERYTHROPOIESIS; GENE DELETION; HETEROZYGOTE; HUMAN; INTRON; IRON OVERLOAD; LIVER DYSFUNCTION; LIVER IRON OVERLOAD; MICROCYTIC ANEMIA; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 30144443274     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-06-2477     Document Type: Article

References (22)

1. Fleming MD, Trenor CC, Su MA, et al. Microcytic anemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet. 1997;16:383-386.
2. Fleming MD, Romano MA, Su MA, Garrick LM, Andrews NC. Nramp2 is mutated in the anemic Begrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci U S A. 1998;95:1148-1153.
3. Gunshin H, Mackenzie B, Berger UV, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 1997;388:482-487.
4. Cannone-Hergaux S, Gruenheid S, Ponka P, Gros P. Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron. Blood. 1999;93:4406-4417.
5. Su M, Trenor CC, Fleming JC, Fleming MD, Andrews NC. The G185R mutation disrupts function of the iron transporter Nramp2. Blood. 1998;92:2157-2163.
6. Touret N, Martin-Orozco N, Paroutis P, et al. Molecular and cellular mechanisms underlying iron transport deficiency in microcytic anemia. Blood. 2004;104:1526-1533
7. Cannone-Hergaux S, Zhang AS, Ponka P, Gros P. Characterization of the iron transporter DMT1 (Nramp2/DCT1) in red blood cells of normal and anaemic mk/mk mice. Blood. 2001;98:3823-3830.
8. Priwitzerova M, Pospisilova D, Prchal JT, et al. Severe hypochromic microcytic anemia caused by a congenital defect of the iron transporter pathway in erythroid cells. Blood. 2004;103:3991-3992.
9. Mims MP, Guan Y, Pospisilova D, et al. Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload. Blood. 2005;105:1337-1342.
10. Tchernia G, Delhommeau F, Perrotta S, et al. Recombinant erythropoietin therapy as an alternative to blood transfusions in infants with hereditary spherocytosis. Hematol J. 2000;1:146-152.
11. Fischer R. Liver iron susceptometry. In: Andrae W, Nowak H, eds. Magnetism in Medicine - a Handbook. Berlin, Germany: Wiley-VHC; 1998:286-301.
12. Brittenham GM, Farrell DE, Harris JW, et al. Magnetic-susceptibility measurement of human iron stores. N Engl J Med. 1982;307:1671-1675.
13. Angelucci E, Brittenham GM, McLaren CE, et al. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med. 2000;343:327-331.
14. Sciot R, van Eyken P, Facchetti F, et al. Hepato-cellular transferrin receptor expression in secondary siderosis. Liver. 1989;9:52-61.
15. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
16. Levy JE, Jin O, Fujiwara Y, et al. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat Genet. 1999;21:396-399.
17. Yu C, Niakan KK, Matsushita M, Stamatoyannopoulos G, Orkin SH, Raskind WH. X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction. Blood. 2002;100:2040-2045.
18. Lee PL, Gelbart T, West C, Halloran C, Beutler E. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms. Blood Cells Mol Dis. 1998;24:199-215.
19. Priwitzerova M, Pospsilova D, Sheftel AD, Dikovy V, Ponka P. Functional consequences of the human DMT1 mutation on protein expression and iron uptake. Presented at: BioIron 2005: First Congress of the International BioIron Society; May 22-26, 2005; Prague, Czech Republic. Abstract 126.
20. Carteggi L, Chew S, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet. 2002;3:285-298.
21. Gunshin H, Fujiwara Y, Custodio AO, Direnzo C, Robine S, Andrews N. SLC11A2 is required for intestinal absorption and erythropoiesis but dispensable in placenta and liver. J Clin Invest. 2005;115:1258-1266.
22. Priwitzerova M, Pospisilova D, Indrak K, Ponka P, Divoky V. Consequences of DMT1 mutation on proliferation and hemoglobinization of erythroid progenitors in vitro [abstract]. Blood. 2004;104:3190.